Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IBRX ImmunityBio > Detailed Quotes

IBRX ImmunityBio

5.500
+0.530+10.66%
Close 09/28 16:00 ET
5.550
+0.050+0.91%
Post Mkt Price 09/28 18:48 ET
High
5.530
Open
5.020
Turnover
10.22M
Low
4.970
Pre Close
4.970
Volume
1.90M
Market Cap
2.20B
P/E(TTM)
Loss
52wk High
10.370
Shares
400.30M
P/E(Static)
Loss
52wk Low
2.600
Float Cap
533.57M
Bid/Ask %
-33.33%
Historical High
45.420
Shs Float
97.01M
Volume Ratio
1.15
Historical Low
0.930
Dividend TTM
--
Div Yield TTM
--
P/B
-5.24
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.95%
Amplitude
11.27%
Avg Price
5.390
Lot Size
1
Float Cap
533.57M
Bid/Ask %
-33.33%
Historical High
45.420
Shs Float
97.01M
Volume Ratio
1.15
Historical Low
0.930
Dividend TTM
--
P/B
-5.24
Dividend LFY
--
Turnover Ratio
1.95%
Amplitude
11.27%
Avg Price
5.390
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA.
CEO: Mr. Richard Adcock
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...